NLRP3 and hepatocellular carcinoma: Indeed, in contrast to our study, estrogens were reported to inhibit NLRP3 inflammasome pathway activation, caspase-1, and proinflammatory cytokine production in the brain after global cerebral ischemia, while activating NLRP3 inflammasome and triggering pyroptosis in hepatocellular carcinoma cells.